Roche (ROG)
International Stocks
Buy
The speaker evaluates Swiss pharma giants Roche and Novartis as having more attractive valuations compared to their US counterparts.
David Herro
CNBC Television
Loading...
Loading...
Coverage, strength, recency, conviction and momentum.
No analyses found yet.
Newest calls at the top.
The speaker evaluates Swiss pharma giants Roche and Novartis as having more attractive valuations compared to their US counterparts.
The speaker evaluates this company as an alternative against regional risks in Danish-based pharmaceutical companies.
The speaker evaluates Swiss pharma giants Roche and Novartis as having more attractive valuations compared to their US counterparts.
The speaker evaluates this company as an alternative against regional risks in Danish-based pharmaceutical companies.